Ads
related to: squamous cell carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Patient Resources
Find Patient Resources
On The Official Site.
- How This Treatment Works
Search results
BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
Zacks via Yahoo Finance· 6 days agoBeigene's (BGNE) shares surge 32% in a month due to the label expansion of one of its key oncology...
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 3 days agoIn November last year, the company concluded the subject enrolment in the Phase III BURAN trial of...
Glenmark to market BeiGene’s oncology medicines in India
Pharmaceutical Technology via Yahoo Finance· 5 days agoIt is under broad development for a range of cancer types. A small molecule inhibitor of Bruton’s...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 2 days agoThursday, Merus N.V. (NASDAQ:MRUS) announced the publication of an abstract regarding petosemtamab...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 7 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...
FOX 5 San Diego· 2 days agoThe data will be presented in a poster at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) on June 2, 2024.
Potential Precursor Lesion to Adrenal Tumors Identified
Medscape· 4 days agoCortisol-producing adenomas (CPAs) are preceded by the development of steroids-producing nodules...
Hammerling-Hodgers: Summer is here. Take protective measures to stay safe from sun's rays
Florida Today via Yahoo News· 5 days agoIf there is a mole that you are born with and changes or a new skin lesion appears and does not go...
Study Finds Radiotherapy for NMSC in Dermatology Growing
Medscape· 6 days agoThe use of radiotherapy has been steadily increasing by dermatologists, according to new findings...
Galectin Therapeutics (NASDAQ:GALT) Upgraded to “Hold” by StockNews.com
ETF DAILY NEWS· 6 days agoGalectin Therapeutics (NASDAQ:GALT – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. Separately, HC ...